SCHIZOPHRENIA UPDATES 2025-2026
The Biggest Story — KarXT (Cobenfy®): The First Non-Dopaminergic Antipsychotic September 2024: A Historic FDA Approval Background: The KarXT Revolution: What Is It? The Ingenious Solution: Phase 3 EMERGENT Trial Results: Real-World Data (2025-2026): December 2024 — Cognitive Improvement Confirmed: Current Studies (2026): Iclepertin Failure — […]
Read More




